✦ LIBER ✦

Fewer endometrial abnormalities with anastrozole than tamoxifen: Endometrial subprotocol results from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) early breast cancer trial in postmenopausal patients

✍ Scribed by Sean Duffy

Book ID: 114315650
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 196 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80125-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P115 Fewer gynaecological adverse events

P115 Fewer gynaecological adverse events (AEs), gynaecological interventions, endometrial changes and abnormalities with anastrozole than with tamoxifen: findings from the ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial

✍ W. Distle 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 150 KB

The ATAC (Arimidex, Tamoxifen, alone or

The ATAC (Arimidex, Tamoxifen, alone or in combination) trial in post-menopausal patients with operable breast cancer

✍ J. Tobias 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Molecular markers in the endometrium at

Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial

✍ Sean R.G. Duffy; Lydia Taylor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

The ATAC (Arimidex™, Tamoxifen, Alone or

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment

✍ Mike Baum 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB